PAIN TRIGGERS
Adderall worsens anger and causes frequent intense outbursts after initial benefits.
Heightened libido from Adderall becomes burdensome alongside mood swings.
Medication inconsistency due to forgetting doses leads to worse symptoms.
SaaS· partners/spouses of ADHD individuals on stimulantsPain 7.00/10WTP 7.0/10Market 8.0/10Validation 7.0Confidence 72%May 22, 2026
SideGuard ADHD: Track and Mitigate Stimulant Side Effects
Adderall delivers focus benefits but triggers worsening anger outbursts, mood instability, and heightened libido that strains partnerships, with users forgetting doses and lacking structured ways to track or address side effects.
ai-poweredconsultantshealthcaremental-healthmobile-appproductivitysaastrackingwellness
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
Adderall improves ADHD focus and task completion but causes increased anger/outbursts, mood swings, and heightened libido that strains relationships.
FREQUENCY
Limited repetition signal.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
At first the Adderall was a godsend, and now I am realizing that it's maybe making things worse.
postAdderall, Anger, Libido
ADHD39
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
partners/spouses of ADHD individuals on stimulantsA D H D Patients And Spouses On Stimulants
Adults prescribed Adderall for ADHD focus who face escalating anger, mood swings, and libido changes, along with partners documenting impacts on relationships.
Context
Find an effective ADHD medication or treatment that manages symptoms without severe anger, mood instability, or unwanted sexual side effects.
Partner takes detailed notes of outbursts to document patterns for couples therapy.
Suggesting to titrate off current med and switch to non-stimulant while continuing therapy.
Current Workarounds
Taking detailed notes of outbursts for therapy sessions
Daily dose reminders to avoid inconsistency crashes
Suggesting manual med switches or titration without professional guidance
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Adderall provides focus benefits but introduces or worsens anger and libido issues without addressed adjustments.
Therapist has not discussed medication changes after a month of visits.
No clear non-stimulant alternatives being explored despite side effects.
OPPORTUNITY & VALUE
Why Now
Repeated mentions of anger outbursts, mood swings turning off partners, and dose inconsistency worsening symptoms.
Value Proposition
Couples-focused tracking of relational side effects like anger and libido, not just individual focus metrics.
Product Direction
A mobile app for daily side effect tracking (anger, mood, libido, focus) with AI pattern reports shared with doctors and partners to facilitate faster medication adjustments or non-stimulant alternatives.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$19/moIndividual + partner access
Model
SaaS subscription
WILLINGNESS TO PAY
Partners are actively documenting outbursts and seeking med changes after seeing relationship damage; users already invest in therapy and would pay for a tool preventing uncompensated emotional labor and med trial-and-error frustration.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Track ADHD med side effects and stabilize mood in 4 weeks.”
A mobile app for daily side effect tracking (anger, mood, libido, focus) with AI pattern reports shared with doctors and partners to facilitate faster medication adjustments or non-stimulant alternatives.
Core Features
Daily mood/anger/libido/focus logging with reminders
Partner-shared reports and joint notes
AI-generated side effect summaries for doctor visits
Basic alternative treatment info library
Weekly Roadmap
1
W1-W2
Core logging system built and functional for solo users.
- •Build daily symptom tracker UI for anger, mood, libido, focus
- •Implement local data storage and basic reminders
- •Set up user authentication
2
W3-W4
Partner sharing and report generation complete.
- •Add partner invite and shared dashboard
- •Create AI summary report generator
- •Implement secure data export for doctors
3
W5
Internal testing and bug fixes with sample ADHD users.
- •Recruit 8 beta users from ADHD communities
- •Polish UI/UX based on feedback
- •Test data export accuracy
4
W6
MVP launched with first subscribers.
- •Set up Stripe payments
- •Deploy to app stores
- •Post in target Reddit communities for initial users
Launch Strategy
ADHD subreddits, partner support forums, and targeted Facebook groups for ADHD couples
RISKS & ASSUMPTIONS
Top Risks
Medical regulatory compliance
Health tracking app must avoid giving direct medical advice; missteps could lead to legal issues.
Data sensitivity and privacy
Handling intimate mood, anger, and libido data requires strong privacy measures to build trust.
User retention after initial tracking
Users may log for a few weeks but drop off if doctor integration or visible improvements are slow.
Partner buy-in
Requires both patient and partner engagement which may be inconsistent during conflicts.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This idea scores in the upper-middle range of opportunities surfaced by MonetScope, with a validation sub-score of 7/10 against 4 independently sourced evidence signals. A "promising" rating usually indicates a real pain has been detected and discussed in the open, but the pipeline did not find enough signal to flag it as urgent or high-frequency. These opportunities can still produce excellent businesses — they often correspond to "boring" problems that established players have ignored — but the founder should expect a longer customer-development cycle to confirm willingness to pay.
Why this matters for SaaS founders
It sits at the intersection of "ai-powered", "consultants", "healthcare", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "SideGuard ADHD: Track and Mitigate Stimulant Side Effects" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for ai-powered?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.